|
|||||
|
|
Reduction of the Total IgE Level by Omalizumab in Children and Adolescents |
|
| Authors: | Raymond G. Slavin Pablo Jimenez |
| Affiliation: | 1. Saint Louis University School of Medicine, Saint Louis, Missouri, United States;2. Novartis Pharmaceuticals Inc, East Hanover, New Jersey, USA |
| Abstract: | |
| Keywords: | |